You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

A Systematic Review of Impulse Control Disorders in Parkinson's Disease

Article type: Review Article

Authors: Callesen, Mette Buhl; | Scheel-Krüger, Jørgen | Kringelbach, Morten L.; | Møller, Arne;

Affiliations: Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital, Aarhus, Denmark | Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark | Department of Psychiatry, Oxford University, UK

Note: [] Correspondence to: Mette Buhl Callesen, Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital, Noerrebrogade 44, Building 10 G, 8000 Aarhus C, Denmark. Tel.: +45 78464405; E-mail: [email protected]

Keywords: Impulse control disorders, Parkinson disease, dopamine, serotonin, neuroanatomy, decision making

DOI: 10.3233/JPD-120165

Journal: Journal of Parkinson's Disease, vol. 3, no. 2, pp. 105-138, 2013

Published: 2013
Get PDF open access
Supplementary Materials:

Supplementary tables

Abstract

Throughout the past decade it has been recognized that dopaminergic medication administered to remedy motor symptoms in Parkinson's disease is associated with an enhanced risk for impulse control disorders and related compulsive behaviors such as hobbyism, punding, and the dopamine dysregulation syndrome. These complications are relatively frequent, affecting 6–15.5% of patients, and they most often appear, or worsen, after initiation of dopaminergic therapy or dosage increase. Recently, impulse control disorders have also been associated with subthalamic nucleus deep brain stimulation. Here we present a systematic overview of literature published between 2000 and January 2013 reporting impulse control disorders in Parkinson's disease. We consider prevalence rates and discuss the functional neuroanatomy, the impact of dopamine-serotonin interactions, and the cognitive symptomatology associated with impulse control disorders in Parkinson's disease. Finally, perspectives for future research and management of impulse control disorders in Parkinson's disease are discussed.

Show more